* **THIS SEMINAR WILL TAKE PLACE ONLINE AND THE LINK WILL BE SHARED TWO HOURS BEFORE THE START OF THE SEMINAR***
This series is co-hosted by the Centre for Global Health, Dalla Lana School of Public Health and the Lawrence S. Bloomberg Faculty of Nursing at the University of Toronto.
OVERVIEW
The commercial determinants of health (CDOH) has emerged as a unifying concept bringing together a growing number of researchers studying a broad range of public health concerns. These include substance use (e.g. tobacco, alcohol, prescription drugs, cannabis), unhealthy products (e.g. sugary drinks, ultra highly processed foods), and other major human health risks (e.g. road traffic accidents, gun violence, air quality and extractive industries, deforestation and zoonotic diseases, agriculture sector and antimicrobial resistance). The rapidly growing evidence on the links between the CDOH and health outcomes has gained the attention of practitioners and advocacy groups. Opportunities for deeper and lasting change, however, require closer engagement with policy makers who are responsible for shaping priorities, creating regulatory frameworks, and allocating public resources for the benefit of societies. This brief talk focuses on lessons for effective engagement with policy makers on the CDOH drawn from experiences at the global, national and local levels.
B IOS
Kelley Lee is Professor and Tier 1 Canada Research Chair in Global Health Governance in the Faculty of Health Sciences, Simon Fraser University. She is also Scientific Co-Director of the Pacific Institute on Pathogens, Pandemics and Society (PIPPS). She was previously Professor of Global Health Policy at the London School of Hygiene and Tropical Medicine where she co-directed the WHO Collaborating Centre on Global Change and Health. Her research focuses on strengthening collective action to mitigate crossborder health risks. She previously led the Global Tobacco Control Research Programme at LSHTM and SFU which secured and conducted detailed analyses of internal tobacco industry documents. She continues to study the commercial determinants of health including serving on the Editorial Board for the WHO Global Report. She currently heads the Pandemics and Borders Project which analyses the use of travel measures during the COVID-19 pandemic. She is a Fellow of the UK Faculty of Public Health, Canadian Academy of Health Sciences, and Royal Society of Canada. She has published 15 books, 200+ papers and 60+ book chapters including the Oxford Handbook of Global Health Politics (edited with Colin McInnes and Jeremy Youde, 2020).
Daniel Eisenkraft Klein is a PhD Candidate at the Dalla Lana School of Public Health and a Fellow at the Canadian Centre for Health Economics, funded by a Social Sciences and Humanities Research Council Doctoral Fellowship. His primary research agenda explores how the tobacco and pharmaceutical industries influence policy stakeholders to provide favourable regulatory environments. Daniel is also a Sessional Instructor at Simon Fraser University on the commercial determinants of health, and serves as an Expert Consultant for Johns Hopkins University’s Opioid Industry Documents Archive.
MODERATOR
Quinn Grundy is a registered nurse and Assistant Professor with the Lawrence S. Bloomberg Faculty of Nursing at the University of Toronto and a Fellow with the WHO Collaborating Centre on Governance, Accountability, and Transparency in the Pharmaceutical Sector. Dr. Grundy’s research explores the interactions between medically-related industry and the public health system. Dr Grundy is the author of Infiltrating Healthcare: How Marketing Works Underground to Influence Nurses (Johns Hopkins University Press, 2018) which details the first in-depth study of the ways that registered nurses interact with pharmaceutical and medical device company representatives.
Register Here
